ESCAPE Bio

ESCAPE Bio is a preclinical-stage biopharmaceutical company dedicated to discovering and developing therapies for the treatment of hereditary neurodegenerative diseases. Our pipeline includes candidates targeting known genetic drivers of various diseases. Our goal is to improve the lives of patients with Alzheimer's disease, Parkinson's disease, and lysosomal storage disorders of the central nervous system.